101
|
Fan B, Jiao D, Zhang R, Zhou J, Guo R, Yu Z, Shi D, Zhao Y, Gu J, Niu B, Ma Z, Gao S, He K, Li B. Origin and epidemic status of porcine epidemic diarrhea virus variants in China. Transbound Emerg Dis 2019; 67:1364-1370. [PMID: 31793242 DOI: 10.1111/tbed.13444] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2019] [Revised: 11/07/2019] [Accepted: 11/27/2019] [Indexed: 12/24/2022]
Abstract
From 2010, porcine epidemic diarrhea virus (PEDV) variants caused sequential outbreaks of disease in Asia and the United States. In this retrospective study, 49 complete spike (S) gene sequences were obtained from PEDV strains collected in China from 2014 to 2016. We observed that variant PEDV strains with novel insertions, deletions, and multiple S gene recombination types were present in China. In addition, mixed infections involving different variant strains were observed in some areas. Based on phylogenetic and recombination analyses, we determined that the newly emerged PEDV variants potentially originated via recombination between the earliest Chinese G1 genogroup strain, JS-2004-2 and earlier Korean pandemic strains. These findings provide important information for understanding ongoing PEDV outbreaks and suggest that novel variants make it more difficult to prevent PEDV infection.
Collapse
Affiliation(s)
- Baochao Fan
- Institute of Veterinary Medicine, Key Laboratory of Veterinary Biological Engineering and Technology, Ministry of Agriculture, Jiangsu Academy of Agricultural Sciences, Nanjing, China.,Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Disease and Zoonoses, Jiangsu Key Laboratory of Zoonosis, Yangzhou University, Yangzhou, China.,Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base of Ministry of Science and Technology, Nanjing, China
| | - Dian Jiao
- Institute of Veterinary Medicine, Key Laboratory of Veterinary Biological Engineering and Technology, Ministry of Agriculture, Jiangsu Academy of Agricultural Sciences, Nanjing, China.,Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Disease and Zoonoses, Jiangsu Key Laboratory of Zoonosis, Yangzhou University, Yangzhou, China
| | - Ruoxi Zhang
- Hebei Provincial Center for Animal Disease Control and Prevention, Shijiazhuang, China
| | - Jinzhu Zhou
- Institute of Veterinary Medicine, Key Laboratory of Veterinary Biological Engineering and Technology, Ministry of Agriculture, Jiangsu Academy of Agricultural Sciences, Nanjing, China.,Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Disease and Zoonoses, Jiangsu Key Laboratory of Zoonosis, Yangzhou University, Yangzhou, China
| | - Rongli Guo
- Institute of Veterinary Medicine, Key Laboratory of Veterinary Biological Engineering and Technology, Ministry of Agriculture, Jiangsu Academy of Agricultural Sciences, Nanjing, China.,Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Disease and Zoonoses, Jiangsu Key Laboratory of Zoonosis, Yangzhou University, Yangzhou, China
| | - Zhengyu Yu
- Institute of Veterinary Medicine, Key Laboratory of Veterinary Biological Engineering and Technology, Ministry of Agriculture, Jiangsu Academy of Agricultural Sciences, Nanjing, China.,Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Disease and Zoonoses, Jiangsu Key Laboratory of Zoonosis, Yangzhou University, Yangzhou, China
| | - Danyi Shi
- Institute of Veterinary Medicine, Key Laboratory of Veterinary Biological Engineering and Technology, Ministry of Agriculture, Jiangsu Academy of Agricultural Sciences, Nanjing, China.,College of Animal Science and Technology, Hebei Normal University of Science and Technology, Qinhuangdao, China
| | - Yongxiang Zhao
- Institute of Veterinary Medicine, Key Laboratory of Veterinary Biological Engineering and Technology, Ministry of Agriculture, Jiangsu Academy of Agricultural Sciences, Nanjing, China.,Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Disease and Zoonoses, Jiangsu Key Laboratory of Zoonosis, Yangzhou University, Yangzhou, China.,Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base of Ministry of Science and Technology, Nanjing, China
| | - Jun Gu
- School of Food and Biological Engineering, Jiangsu University, Zhenjiang, China
| | - Beibei Niu
- Institute of Veterinary Medicine, Key Laboratory of Veterinary Biological Engineering and Technology, Ministry of Agriculture, Jiangsu Academy of Agricultural Sciences, Nanjing, China.,Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Disease and Zoonoses, Jiangsu Key Laboratory of Zoonosis, Yangzhou University, Yangzhou, China.,College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, China
| | - Zengjun Ma
- College of Animal Science and Technology, Hebei Normal University of Science and Technology, Qinhuangdao, China
| | - Song Gao
- Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Disease and Zoonoses, Jiangsu Key Laboratory of Zoonosis, Yangzhou University, Yangzhou, China
| | - Kongwang He
- Institute of Veterinary Medicine, Key Laboratory of Veterinary Biological Engineering and Technology, Ministry of Agriculture, Jiangsu Academy of Agricultural Sciences, Nanjing, China.,Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Disease and Zoonoses, Jiangsu Key Laboratory of Zoonosis, Yangzhou University, Yangzhou, China.,Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base of Ministry of Science and Technology, Nanjing, China
| | - Bin Li
- Institute of Veterinary Medicine, Key Laboratory of Veterinary Biological Engineering and Technology, Ministry of Agriculture, Jiangsu Academy of Agricultural Sciences, Nanjing, China.,Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Disease and Zoonoses, Jiangsu Key Laboratory of Zoonosis, Yangzhou University, Yangzhou, China.,Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base of Ministry of Science and Technology, Nanjing, China.,School of Food and Biological Engineering, Jiangsu University, Zhenjiang, China.,College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, China
| |
Collapse
|
102
|
Yu Z, Li N, Jiang K, Zhang N, Yao LL. MiR-100 up-regulation enhanced cell autophagy and apoptosis induced by cisplatin in osteosarcoma by targeting mTOR. Eur Rev Med Pharmacol Sci 2019; 22:5867-5873. [PMID: 30280766 DOI: 10.26355/eurrev_201809_15913] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE Mammalian target of rapamycin (mTOR) can negatively regulate cell autophagy, while its expression and activity are associated with the pathogenesis of osteosarcoma. MicroRNA 100 (MiR-100) down-regulation is associated with the pathogenesis and chemo-sensitivity of osteosarcoma. Bioinformatics analysis revealed the targeted relationship between miR-100 and the 3'-UTR of mTOR. We investigate the role of miR-100 in affecting mTOR expression, osteosarcoma cell autophagy, and sensitivity to cisplatin. PATIENTS AND METHODS MiR-100, mTOR, and Beclin-1 expressions in osteosarcoma tissue and normal control were compared. The relationship between miR-100 and mTOR was verified by dual luciferase assay. MiR-100, mTOR, and Beclin-1 levels in MG-63 cells and MG-63/DDP cells were tested. Cell apoptosis was determined by using flow cytometry. Cell malignancy was evaluated by colony formation assay. RESULTS MiR-100 and Beclin-1 significantly declined, while mTOR significantly increased in osteosarcoma tissue compared with that of normal tissue (p<0.05). MiR-100 targeting significantly inhibited mTOR expression compared to that of untreated (p<0.05). MiR-100 expression was down-regulated and mTOR level was elevated in MG-63/DDP cells compared with MG-63 cells (p<0.05). MG-63/DDP cells exhibited reduced cell autophagy and apoptosis, and enhanced colony formation induced by DDP. MiR-100 mimic and/or small interfere mTOR (si-mTOR) significantly promoted Beclin-1 expression, cell autophagy, and cell apoptosis, while attenuated colony formation. CONCLUSIONS MiR-100 declined, while mTOR up-regulated in osteosarcoma tissue. MiR-100 up-regulation enhanced cell autophagy and apoptosis induced by cisplatin via targeted inhibiting of mTOR.
Collapse
Affiliation(s)
- Z Yu
- Department of Medical Oncology, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
| | | | | | | | | |
Collapse
|
103
|
Walker JT, Beachley G, Amos HM, Baron JS, Bash J, Baumgardner R, Bell MD, Benedict KB, Chen X, Clow DW, Cole A, Coughlin JG, Cruz K, Daly RW, Decina SM, Elliott EM, Fenn ME, Ganzeveld L, Gebhart K, Isil SS, Kerschner BM, Larson RS, Lavery T, Lear GG, Macy T, Mast MA, Mishoe K, Morris KH, Padgett PE, Pouyat RV, Puchalski M, Pye HOT, Rea AW, Rhodes MF, Rogers CM, Saylor R, Scheffe R, Schichtel BA, Schwede DB, Sexstone GA, Sive BC, Sosa Echeverría R, Templer PH, Thompson T, Tong D, Wetherbee GA, Whitlow TH, Wu Z, Yu Z, Zhang L. Toward the improvement of total nitrogen deposition budgets in the United States. Sci Total Environ 2019; 691:1328-1352. [PMID: 31466212 PMCID: PMC7724633 DOI: 10.1016/j.scitotenv.2019.07.058] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/14/2019] [Revised: 07/02/2019] [Accepted: 07/04/2019] [Indexed: 06/10/2023]
Abstract
Frameworks for limiting ecosystem exposure to excess nutrients and acidity require accurate and complete deposition budgets of reactive nitrogen (Nr). While much progress has been made in developing total Nr deposition budgets for the U.S., current budgets remain limited by key data and knowledge gaps. Analysis of National Atmospheric Deposition Program Total Deposition (NADP/TDep) data illustrates several aspects of current Nr deposition that motivate additional research. Averaged across the continental U.S., dry deposition contributes slightly more (55%) to total deposition than wet deposition and is the dominant process (>90%) over broad areas of the Southwest and other arid regions of the West. Lack of dry deposition measurements imposes a reliance on models, resulting in a much higher degree of uncertainty relative to wet deposition which is routinely measured. As nitrogen oxide (NOx) emissions continue to decline, reduced forms of inorganic nitrogen (NHx = NH3 + NH4+) now contribute >50% of total Nr deposition over large areas of the U.S. Expanded monitoring and additional process-level research are needed to better understand NHx deposition, its contribution to total Nr deposition budgets, and the processes by which reduced N deposits to ecosystems. Urban and suburban areas are hotspots where routine monitoring of oxidized and reduced Nr deposition is needed. Finally, deposition budgets have incomplete information about the speciation of atmospheric nitrogen; monitoring networks do not capture important forms of Nr such as organic nitrogen. Building on these themes, we detail the state of the science of Nr deposition budgets in the U.S. and highlight research priorities to improve deposition budgets in terms of monitoring and flux measurements, leaf- to regional-scale modeling, source apportionment, and characterization of deposition trends and patterns.
Collapse
Affiliation(s)
- J T Walker
- U.S. Environmental Protection Agency, Office of Research and Development, Durham, NC, United States of America.
| | - G Beachley
- U.S. Environmental Protection Agency, Office of Air and Radiation, Washington, DC, United States of America
| | - H M Amos
- AAAS Science and Technology Policy Fellow hosted by the U.S. Environmental Protection Agency, Office of Research and Development, Washington, DC, United States of America
| | - J S Baron
- U.S. Geological Survey, Fort Collins Science Center, Fort Collins, CO, United States of America
| | - J Bash
- U.S. Environmental Protection Agency, Office of Research and Development, Durham, NC, United States of America
| | - R Baumgardner
- U.S. Environmental Protection Agency, Office of Research and Development, Durham, NC, United States of America
| | - M D Bell
- National Park Service, Air Resources Division, Lakewood, CO, United States of America
| | - K B Benedict
- Colorado State University, Department of Atmospheric Science, Fort Collins, CO, United States of America
| | - X Chen
- U.S. Environmental Protection Agency, Office of Research and Development, Durham, NC, United States of America
| | - D W Clow
- U.S. Geological Survey, Colorado Water Science Center, Denver, CO, United States of America
| | - A Cole
- Environment and Climate Change Canada, Air Quality Research Division, Toronto, ON, Canada
| | - J G Coughlin
- U.S. Environmental Protection Agency, Region 5, Chicago, IL, United States of America
| | - K Cruz
- U.S. Department of Agriculture, National Institute of Food and Agriculture, Washington, DC, United States of America
| | - R W Daly
- U.S. Environmental Protection Agency, Office of Research and Development, Durham, NC, United States of America
| | - S M Decina
- University of California, Department of Chemistry, Berkeley, CA, United States of America
| | - E M Elliott
- University of Pittsburgh, Department of Geology & Environmental Science, Pittsburgh, PA, United States of America
| | - M E Fenn
- U.S. Department of Agriculture, Forest Service, Pacific Southwest Research Station, Riverside, CA, United States of America
| | - L Ganzeveld
- Meteorology and Air Quality (MAQ), Wageningen University and Research Centre, Wageningen, Netherlands
| | - K Gebhart
- National Park Service, Air Resources Division, Fort Collins, CO, United States of America
| | - S S Isil
- Wood Environment & Infrastructure Solutions, Inc., Newberry, FL, United States of America
| | - B M Kerschner
- Prairie Research Institute, University of Illinois, Champaign, IL, United States of America
| | - R S Larson
- Wisconsin State Laboratory of Hygiene, University of Wisconsin, Madison, WI, United States of America
| | - T Lavery
- Environmental Consultant, Cranston, RI, United States of America
| | - G G Lear
- U.S. Environmental Protection Agency, Office of Air and Radiation, Washington, DC, United States of America
| | - T Macy
- U.S. Environmental Protection Agency, Office of Air and Radiation, Washington, DC, United States of America
| | - M A Mast
- U.S. Geological Survey, Colorado Water Science Center, Denver, CO, United States of America
| | - K Mishoe
- Wood Environment & Infrastructure Solutions, Inc., Newberry, FL, United States of America
| | - K H Morris
- National Park Service, Air Resources Division, Lakewood, CO, United States of America
| | - P E Padgett
- U.S. Department of Agriculture, Forest Service, Pacific Southwest Research Station, Riverside, CA, United States of America
| | - R V Pouyat
- U.S. Forest Service, Bethesda, MD, United States of America
| | - M Puchalski
- U.S. Environmental Protection Agency, Office of Air and Radiation, Washington, DC, United States of America
| | - H O T Pye
- U.S. Environmental Protection Agency, Office of Research and Development, Durham, NC, United States of America
| | - A W Rea
- U.S. Environmental Protection Agency, Office of Research and Development, Durham, NC, United States of America
| | - M F Rhodes
- D&E Technical, Urbana, IL, United States of America
| | - C M Rogers
- Wood Environment & Infrastructure Solutions, Inc., Newberry, FL, United States of America
| | - R Saylor
- National Oceanic and Atmospheric Administration, Air Resources Laboratory, Oak Ridge, TN, United States of America
| | - R Scheffe
- U.S. Environmental Protection Agency, Office of Air Quality Planning and Standards, Durham, NC, United States of America
| | - B A Schichtel
- National Park Service, Cooperative Institute for Research in the Atmosphere, Colorado State University, Fort Collins, CO, United States of America
| | - D B Schwede
- U.S. Environmental Protection Agency, Office of Research and Development, Durham, NC, United States of America
| | - G A Sexstone
- U.S. Geological Survey, Colorado Water Science Center, Denver, CO, United States of America
| | - B C Sive
- National Park Service, Air Resources Division, Lakewood, CO, United States of America
| | - R Sosa Echeverría
- Centro de Ciencias de la Atmosfera, Universidad Nacional Autónoma de México, Mexico
| | - P H Templer
- Boston University, Department of Biology, Boston, MA, United States of America
| | - T Thompson
- AAAS Science and Technology Policy Fellow hosted by the U.S. Environmental Protection Agency, Office of Policy, Washington, DC, United States of America
| | - D Tong
- George Mason University. National Oceanic and Atmospheric Administration, Air Resources Laboratory, College Park, MD, United States of America
| | - G A Wetherbee
- U.S. Geological Survey, Hydrologic Networks Branch, Denver, CO, United States of America
| | - T H Whitlow
- Cornell University, Department of Horticulture, Ithaca, NY, United States of America
| | - Z Wu
- U.S. Environmental Protection Agency, Office of Research and Development, Durham, NC, United States of America
| | - Z Yu
- University of Pittsburgh, Department of Geology & Environmental Science, Pittsburgh, PA, United States of America
| | - L Zhang
- Environment and Climate Change Canada, Air Quality Research Division, Toronto, ON, Canada
| |
Collapse
|
104
|
Yu Z, Li W, Tan S. Real-time monitoring of the membrane biofouling based on spectroscopic analysis in a marine MBBR-MBR (moving bed biofilm reactor-membrane bioreactor) for saline wastewater treatment. Chemosphere 2019; 235:1154-1161. [PMID: 31561306 DOI: 10.1016/j.chemosphere.2019.07.005] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/24/2019] [Revised: 06/06/2019] [Accepted: 07/01/2019] [Indexed: 06/10/2023]
Abstract
A MBBR-MBR system has been developed with marine microorganisms enriched for saline wastewater treatment in this work, showing high COD and NH3-N removals. The behaviour of fouling-related components (EPS and SMP) has been studied as functions of operating time (40-90 days), salinity (0-30 g/L NaCl) and backflow ratio (0-300%, from MBR to MBBR). High biodegradability of the MBBR-MBR at optimal conditions can induce more biodegradation of humic acid-like (λex/λem: 350nm/430 nm) and fulvic acid-like (260nm/445 nm) molecules to soluble microbial by-product-like molecules (275nm/325 nm), reducing the membrane biofouling rate. The biodegradation process is suggested by the excitation-emission matrix (EEM) images. In the study of sudden salinity shock, results show that real-time monitoring the concentration of biofoulants is more effective (operative time extended by 60%) than monitoring the transmembrane pressure (operative time extended by 33%) to prevent membrane fouling. Due to an early warning from the real-time monitoring, the coming membrane-fouling is predictable and the operating conditions, such as backflow ratio, can be changed to minimize the biofouling rate.
Collapse
Affiliation(s)
- Zhengyu Yu
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan 410013, China; Faculty of Engineering and Information Technology, University of Technology Sydney, Sydney, NSW, 2007, Australia
| | - Weiguo Li
- Department of Environmental Engineering, Harbin Institute of Technology (Weihai), Weihai, Shandong, 264209, China
| | - Songwen Tan
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan 410013, China; Department of Environmental Engineering, Harbin Institute of Technology (Weihai), Weihai, Shandong, 264209, China.
| |
Collapse
|
105
|
Yu Z, Li XM, Huai M, Cao SS, Han HY, Liu HT. [Expression of NUSAP1 and its relationship with prognosis in non-small cell lung cancer]. Zhonghua Zhong Liu Za Zhi 2019; 41:522-526. [PMID: 31357839 DOI: 10.3760/cma.j.issn.0253-3766.2019.07.007] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the expression of nucleolar and spindle-associated protein 1 (NUSAP1) in non-small cell lung cancer (NSCLC) and analyze its relationship with the prognosis of NSCLC patients. Methods: Real-time fluorescent quantitative PCR and immunohistochemical staining were performed to determine the expression of NUSAP1 in NSCLC tissues and adjacent tissues collected from hospital. The relationship between NUSAP1 expression and prognosis of NSCLC patients was analyzed by online database. Results: The expression level of NUSAP1 mRNA in tumor tissues was significantly higher than that of adjacent tissues (P<0.05). The high expression rate of NUSAP1 protein in NSCLC tissues was 58.0% (29/50), significantly higher than 22.0% (11/50) of adjacent tissues (P<0.05). The high expression of NUSAP1 protein in NSCLC tissues was closely correlated with tumor size, lymph node metastasis and TNM stage (P<0.05), but was not related to age and gender. The data showed that the expression level of NUSAP1 mRNA was inversely associated with the overall survival (OS) of NSCLC patients (P<0.001). The expression of NUSAP1 mRNA was significantly correlated with the pathological grade, clinical stage, gender, chemotherapy, smoking history, and histological type of NSCLC patients (P<0.05). Conclusions: The expression of NUSAP1 is up-regulated in NSCLC, which is correlated with the growth and development of NSCLC and prognosis of the patients. These results indicate that NUSAP1 can be used as a potential prognostic marker for NSCLC.
Collapse
Affiliation(s)
- Z Yu
- Department of Cardiothoracic Medicine, North China Petroleum Administration Bureau General Hospital, Renqiu 062552, China
| | - X M Li
- Department of Pathology, North China Petroleum Administration Bureau General Hospital, Renqiu 062552, China
| | - M Huai
- Department of Thoracic surgery, North China Petroleum Administration Bureau General Hospital, Renqiu 062552, China
| | - S S Cao
- Department of Pathology, North China Petroleum Administration Bureau General Hospital, Renqiu 062552, China
| | - H Y Han
- Department of Thoracic surgery, Pingdu Traditional Chinese Medicine Hospital, Qingdao 266700, China
| | - H T Liu
- Department of Respiratory Medicine, North China Petroleum Administration Bureau General Hospital, Renqiu 062552, China
| |
Collapse
|
106
|
King J, Bhat S, Heath LJ, Derington CG, Yu Z, Clark NP, Witt DM, Reynolds K, Lang DT, Xu S, Bellows BK. P5239Cost-effectiveness of direct oral anticoagulants for cancer-associated venous thromboembolism. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.0212] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Direct oral anticoagulants (DOACs) are at least as effective as low-molecular weight heparins (LMWH) at preventing recurrence after cancer-associated venous thromboembolism (CA-VTE). DOACs are also oral and far less costly, but they may confer a higher bleeding risk than LMWH.
Purpose
To estimate the cost-effectiveness of DOACs and LMWHs for CA-VTE.
Methods
We developed a health state transition model to estimate recurrent VTE, bleeding events, quality-adjusted life years (QALY), and direct healthcare costs (2018 United States dollars) associated with DOACs vs. LMWH use. The model had four states: (1) long-term anticoagulation (first 3 months after VTE), (2) extended anticoagulation (more than 3 months after VTE), (3) off anticoagulants, and (4) death. We used a United States healthcare sector perspective, 3-month cycle length, and 1-year time horizon. Event probabilities were derived from the Hokusai Cancer VTE trial and other literature. Event and medication costs were obtained from national sources. We used a threshold of less than $50,000 per QALY gained to define cost-effectiveness.
Results
Compared to LMWH, DOACs were less costly (mean costs: $8,477 vs. $33,917 per year) and similarly effective (mean QALY: 0.616 vs. 0.622). The incremental cost-effectiveness ratio was $4,479,374 per QALY gained with LMWH, indicating that DOACs are cost-effective (Table 1). In threshold analyses, LMWH therapy only became cost-effective when DOAC recurrent VTE risk increased to at least 72% (relative risk vs. LMWH, 6.19) or DOAC clinically relevant bleeding increased to at least 39% (relative risk vs. LMWH, 10.09).
Scenarios Recurrent VTE, % Major bleed, % Mean difference DOAC − LMW ICER DOAC LMWH Relative Risk DOAC LMWH Relative Risk Cost QALY Base case 8.1 11.6 0.71 6.8 4.0 1.75 −$25,440 (−26,496, −24,274) −0.006 (−0.019, 0.008) $4,479,374 DOAC outcome rate threshold at which LMWH becomes cost-effective* Recurrent VTE 71.5 11.7 6.19 – – – −$6,064 (−7,534, −4,627) −0.121 (−0.136, −0.108) $49,886 Major Bleed – – – 38.9 4.0 10.09 −$2,192 (−3,400, −704) −0.044 (−0.056, −0.030) $49,878 DOAC = direct oral anticoagulant, ICER = incremental cost-effectiveness ratio, LMWH = low-molecular-weight heparin, VTE = venous thromboembolism. Values are mean (95% Uncertainty Interval). Uncertainty was derived from 1,000 stochastic model iterations. *Represents the minimum increased risk with DOAC that would result in LMWH achieving an ICER <$50K per QALY gained.
Conclusion
In this simulation study, DOACs were a cost-effective oral alternative to LMWH for the treatment of CA-VTE. For LMWH to be cost-effective, DOAC event rates needed to be far higher than what is likely to be observed in clinical practice.
Acknowledgement/Funding
Agency for Health Research and Quality R18HS026156
Collapse
Affiliation(s)
- J King
- University of Utah, Salt Lake City, United States of America
| | - S Bhat
- Boston Medical Center, Boston, United States of America
| | - L J Heath
- University of Utah, Salt Lake City, United States of America
| | - C G Derington
- University of Colorado, Aurora, United States of America
| | - Z Yu
- University of Utah, Salt Lake City, United States of America
| | - N P Clark
- Kaiser Permanente Colorado, Aurora, United States of America
| | - D M Witt
- University of Utah, Salt Lake City, United States of America
| | - K Reynolds
- Kaiser Permanente Southern California, Pasadena, United States of America
| | - D T Lang
- Kaiser Permanente Southern California, Pasadena, United States of America
| | - S Xu
- Kaiser Permanente Colorado, Aurora, United States of America
| | - B K Bellows
- Columbia University Medical Center, New York, United States of America
| |
Collapse
|
107
|
Liu H, Ma Y, Yu Z, Zhang C, Wang G, Liu H, Wang G. EP1.18-20 Sleeve Lobectomy for Centrally Located Non-Small Cell Lung Cancer: Initial Short-Term Results from a Single Institute in Northeast China. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.2465] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
108
|
Chi Y, Yao Y, Fang Z, Wang S, Huang G, Cai Q, Shang G, Wang G, Qu G, Wu Q, Jiang Y, Song J, Chen J, Zhu X, Cai Z, Bai C, Lu Y, Yu Z, Shen J, Cai J. Efficacy and safety of anlotinib in advanced leiomyosarcoma: Subgroup analysis of a phase IIB trial (ALTER0203). Ann Oncol 2019. [DOI: 10.1093/annonc/mdz283.026] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
109
|
Fang Z, Yao Y, Cai J, Chi Y, Wang S, Huang G, Cai Q, Shang G, Wang G, Qu G, Wu Q, Jiang Y, Song J, Chen J, Cai Z, Zhu X, Bai C, Lu Y, Yu Z, Shen J. The effect of treatment line on the efficacy of anlotinib hydrochloride in advanced alveolar soft part sarcoma patients. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz283.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
110
|
XU L, Liu Y, Fan Z, Jiang Z, Liu Y, Ling R, Zhang J, Yu Z, Jin F, Wang C, Cui S, Wang S, Mao D, Xiang Q, Zhang Z, Zhou B, Liu Z, Ma C, Duan X, Cui Y. Assessment of CPS+EG, neo-bioscore and modified neo-bioscore in breast cancer patients treated with preoperative systemic therapy: A multicenter cohort study. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz240.073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
111
|
Hamilton E, Vidula N, Ma C, LoRusso P, Bagley R, Yu Z, Annett M, Weitzman A, Conlan M, Weise A. Phase I dose escalation study of a selective androgen receptor modulator RAD140 in estrogen receptor positive (ER+), HER2 negative (HER2-) breast cancer (BC). Ann Oncol 2019. [DOI: 10.1093/annonc/mdz242.038] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
112
|
Zhang C, Wang G, Yu Z, Liu H. P1.17-20 Evaluation of Efficacy and Safety of Uniportal Segmentectomy in the Treatment of Lung Cancer. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1294] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
113
|
Wu Y, Han B, Shi M, Tu H, Gu A, Huang C, Wang H, Yu Z, Wang X, Cao L, Shu Y, Wang H, Yang R, Li X, Chang J, Hu Y, Shen P, Hu Y, Guo Z, Tao M, Zhang Y, Liu X, Sun Q, Zhang X, Jiang Z, Zhao J, Chen F, Sun J, Li D, Zhou J. MA13.11 A Randomized Phase III Study of Cisplatin-Polymeric Micelle Paclitaxel vs Cisplatin-Solvent-Based Paclitaxel in 1st Line Advanced NSCLC. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.609] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
114
|
Luo L, Wang S, Zhu L, Fan B, Liu T, Wang L, Zhao P, Dang Y, Sun P, Chen J, Zhang Y, Chang X, Yu Z, Wang H, Guo R, Li B, Zhang K. Aminopeptidase N-null neonatal piglets are protected from transmissible gastroenteritis virus but not porcine epidemic diarrhea virus. Sci Rep 2019; 9:13186. [PMID: 31515498 PMCID: PMC6742759 DOI: 10.1038/s41598-019-49838-y] [Citation(s) in RCA: 25] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2019] [Accepted: 08/30/2019] [Indexed: 01/30/2023] Open
Abstract
Swine enteric diseases have caused significant economic loss and have been considered as the major threat to the global swine industry. Several coronaviruses, including transmissible gastroenteritis virus (TGEV) and porcine epidemic diarrhea virus (PEDV), have been identified as the causative agents of these diseases. Effective measures to control these diseases are lacking. The major host cells of transmissible gastroenteritis virus and porcine epidemic diarrhea virus have thought to be epithelial cells on small intestine villi. Aminopeptidase-N (APN) has been described as the putative receptor for entry of transmissible gastroenteritis virus and porcine epidemic diarrhea virus into cells in vitro. Recently, Whitworth et al. have reported that APN knockout pigs are resistant to TGEV but not PEDV after weaning. However, it remains unclear if APN-null neonatal pigs are protected from TGEV. Here we report the generation of APN-null pigs by using CRISPR/Cas9 technology followed by somatic cell nuclear transfer. APN-null pigs are produced with normal pregnancy rate and viability, indicating lack of APN is not embryonic lethal. After viral challenge, APN-null neonatal piglets are resistant to highly virulent transmissible gastroenteritis virus. Histopathological analyses indicate APN-null pigs exhibit normal small intestine villi, while wildtype pigs show typical lesions in small intestines. Immunochemistry analyses confirm that no transmissible gastroenteritis virus antigen is detected in target tissues in APN-null piglets. However, upon porcine epidemic diarrhea virus challenge, APN-null pigs are still susceptible with 100% mortality. Collectively, this report provides a viable tool for producing animals with enhanced resistance to TGEV and clarifies that APN is dispensable for the PEDV infection in pigs.
Collapse
Affiliation(s)
- Lei Luo
- Laboratory of Mammalian Molecular Embryology, College of Animal Sciences, Zhejiang University, Hangzhou, Zhejiang, 310058, China.,College of Animal Science and Technology, Anhui Agricultural University, Hefei, Anhui, 230036, China
| | - Shaohua Wang
- Laboratory of Mammalian Molecular Embryology, College of Animal Sciences, Zhejiang University, Hangzhou, Zhejiang, 310058, China
| | - Lin Zhu
- Institute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences, Key Laboratory of Veterinary Biological Engineering and Technology, Ministry of Agriculture, Nanjing, Jiangsu, 210014, China
| | - Baochao Fan
- Institute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences, Key Laboratory of Veterinary Biological Engineering and Technology, Ministry of Agriculture, Nanjing, Jiangsu, 210014, China
| | - Tong Liu
- Laboratory of Mammalian Molecular Embryology, College of Animal Sciences, Zhejiang University, Hangzhou, Zhejiang, 310058, China
| | - Lefeng Wang
- Laboratory of Mammalian Molecular Embryology, College of Animal Sciences, Zhejiang University, Hangzhou, Zhejiang, 310058, China
| | - Panpan Zhao
- Laboratory of Mammalian Molecular Embryology, College of Animal Sciences, Zhejiang University, Hangzhou, Zhejiang, 310058, China
| | - Yanna Dang
- Laboratory of Mammalian Molecular Embryology, College of Animal Sciences, Zhejiang University, Hangzhou, Zhejiang, 310058, China
| | - Pei Sun
- College of Animal Science and Technology, Anhui Agricultural University, Hefei, Anhui, 230036, China
| | - Jianwen Chen
- College of Animal Science and Technology, Anhui Agricultural University, Hefei, Anhui, 230036, China
| | - Yunhai Zhang
- College of Animal Science and Technology, Anhui Agricultural University, Hefei, Anhui, 230036, China
| | - Xinjian Chang
- Institute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences, Key Laboratory of Veterinary Biological Engineering and Technology, Ministry of Agriculture, Nanjing, Jiangsu, 210014, China
| | - Zhengyu Yu
- Institute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences, Key Laboratory of Veterinary Biological Engineering and Technology, Ministry of Agriculture, Nanjing, Jiangsu, 210014, China
| | - Huanan Wang
- Laboratory of Mammalian Molecular Embryology, College of Animal Sciences, Zhejiang University, Hangzhou, Zhejiang, 310058, China
| | - Rongli Guo
- Institute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences, Key Laboratory of Veterinary Biological Engineering and Technology, Ministry of Agriculture, Nanjing, Jiangsu, 210014, China
| | - Bin Li
- Institute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences, Key Laboratory of Veterinary Biological Engineering and Technology, Ministry of Agriculture, Nanjing, Jiangsu, 210014, China. .,Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou, Jiangsu, 225000, China. .,School of Food and Biological Engineering, Jiangsu University, Zhenjiang, 212013, China.
| | - Kun Zhang
- Laboratory of Mammalian Molecular Embryology, College of Animal Sciences, Zhejiang University, Hangzhou, Zhejiang, 310058, China.
| |
Collapse
|
115
|
Ni X, Qu Y, Wang J, Chen F, Cai H, Yu Y, Yu Y, Yu Z, Cen Z, Chen Z. P11.01 TMZ-LEV- IFN cocktail regimen significantly inhibited the growth of glioma. Neuro Oncol 2019. [DOI: 10.1093/neuonc/noz126.147] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
BACKGROUND
TMZ, is the first line chemotherapeutic drug for glioma, and drug resistance is one of the most important reasons for glioma treatment failure. Our previous studies have found that: 1) Type I interferon (IFN) could reverse the resistance of TMZ by inhibiting NF-κB activity, and down-regulating the expression of MGMT in vivo and in vitro; 2) IFN-α could significantly improve chemtherapeautic effect of TMZ for GBM patients. We aim to investigate the therapeutic effect of a cocktail chemotherapy regimen combining temozolomide (TMZ)- Levetiracetam(LEV) - interferon (IFN) on human glioma U138 and U251 subcutaneous xenograft tumor.
MATERIAL AND METHODS
30 xenograft tumors were established by subcutaneously injecting 1×106 glioma cells into the right flank of 4-week-old female BALB/C nude mice and then randomly divided into 5 groups (n=6/group): Control group; TMZ group; TMZ+IFN group; TMZ+LEV group; TMZ+LEV+IFN group. Anti-tumor efficacy of five regimens for tumor-bearing mice was tested after treatment with TMZ (50 mg/kg, i.p.), IFN (2×105 IU, s.c.), LEV (150 mg/kg, i.p.), while TMZ dose were reduced to 12.5 mg/kg for U251 tumors. All drugs are given once a day for five consecutive days. After therapy, the size of tumor was measured every day until the control tumors reached 2000 mm3. Mice bearing U138 tumors were sacrificed at 40 days after therapy, and mice bearing U251 tumors were killed at 26 days after therapy.
RESULTS
We identified that both U138 and U251 tumor growth among TMZ group, TMZ+IFN group, TMZ+LEV group and TMZ+LEV+IFN group were significantly inhibited (P<0.05), compared with the control group. Tumor weight of all treating group was lower than that of the control group (P<0.05). The tumor weight of TMZ+LEV+IFN group was the lowest and significantly lower than that of TMZ+LEV group and TMZ group (P<0.05, respectively). No significant difference was found between TMZ+LEV+IFN group and TMZ+IFN group in U251 subcutaneous xenograft tumors, although the tumor weight was lower in TMZ+LEV+IFN group (P>0.05). In the treatment of mice bearing U138 glioma, TMZ+LEV+IFN regimen was significantly superior to TMZ+IFN regimen.
CONCLUSION
Our data demonstrate that both IFN and LEV can sensitize TMZ effect on glioma. TMZ-LEV-IFN cocktail appears the best regimen.
Collapse
Affiliation(s)
- X Ni
- Department of Neurosurgery, Sun Yat-sen University Cancer Center, Guang zhou, China
| | - Y Qu
- Department of Neurosurgery, Sun Yat-sen University Cancer Center, Guang zhou, China
| | - J Wang
- Department of Neurosurgery, Sun Yat-sen University Cancer Center, Guang zhou, China
| | - F Chen
- Department of Neurosurgery, Sun Yat-sen University Cancer Center, Guang zhou, China
| | - H Cai
- Department of Neurosurgery, Sun Yat-sen University Cancer Center, Guang zhou, China
| | - Y Yu
- Department of Neurosurgery, Sun Yat-sen University Cancer Center, Guang zhou, China
| | - Y Yu
- Department of Neurosurgery, Sun Yat-sen University Cancer Center, Guang zhou, China
| | - Z Yu
- Department of Neurosurgery, Sun Yat-sen University Cancer Center, Guang zhou, China
| | - Z Cen
- Department of Neurosurgery, Sun Yat-sen University Cancer Center, Guang zhou, China
| | - Z Chen
- Department of Neurosurgery, Sun Yat-sen University Cancer Center, Guang zhou, China
| |
Collapse
|
116
|
Zhao X, Wang S, Tang Y, Jing H, Zhang J, Wang J, Song Y, Jin J, Liu Y, Ren H, Fang H, Yu Z, Liu X, LI Y. Chest Wall and Supraclavicular/Infraclavicular Nodal Region are Common Sites of Locoregional Recurrence for Women with Breast Cancer after Mastectomy Irrespective of TN Stage or Molecular Subtypes. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.2373] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
117
|
Yan P, Qiu Z, Zhang T, Li Y, Wang W, Li M, Yu Z, Liu J. Microbial diversity in the tick Argas japonicus (Acari: Argasidae) with a focus on Rickettsia pathogens. Med Vet Entomol 2019; 33:327-335. [PMID: 30839128 DOI: 10.1111/mve.12373] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/24/2018] [Revised: 01/18/2019] [Accepted: 02/12/2019] [Indexed: 05/17/2023]
Abstract
The soft tick Argas japonicus mainly infests birds and can cause human dermatitis; however, no pathogen has been identified from this tick species in China. In the present study, the microbiota in A. japonicus collected from an epidemic community was explored, and some putative Rickettsia pathogens were further characterized. The results obtained indicated that bacteria in A. japonicus were mainly ascribed to the phyla Proteobacteria, Firmicutes and Actinobacteria. At the genus level, the male A. japonicus harboured more diverse bacteria than the females and nymphs. The bacteria Alcaligenes, Pseudomonas, Rickettsia and Staphylococcus were common in nymphs and adults. The abundance of bacteria belonging to the Rickettsia genus in females and males was 7.27% and 10.42%, respectively. Furthermore, the 16S rRNA gene of Rickettsia was amplified and sequenced, and phylogenetic analysis revealed that 13 sequences were clustered with the spotted fever group rickettsiae (Rickettsia heilongjiangensis and Rickettsia japonica) and three were clustered with Rickettsia limoniae, which suggested that the characterized Rickettsia in A. japonicus were novel putative pathogens and also that the residents were at considerable risk for infection by tick-borne pathogens.
Collapse
Affiliation(s)
- P Yan
- Hebei Key Laboratory of Animal Physiology, Biochemistry and Molecular Biology, College of Life Sciences, Hebei Normal University, Shijiazhuang, China
| | - Z Qiu
- Hebei Key Laboratory of Animal Physiology, Biochemistry and Molecular Biology, College of Life Sciences, Hebei Normal University, Shijiazhuang, China
| | - T Zhang
- Hebei Key Laboratory of Animal Physiology, Biochemistry and Molecular Biology, College of Life Sciences, Hebei Normal University, Shijiazhuang, China
| | - Y Li
- Hebei Key Laboratory of Animal Physiology, Biochemistry and Molecular Biology, College of Life Sciences, Hebei Normal University, Shijiazhuang, China
| | - W Wang
- Hebei Key Laboratory of Animal Physiology, Biochemistry and Molecular Biology, College of Life Sciences, Hebei Normal University, Shijiazhuang, China
| | - M Li
- Hebei Key Laboratory of Animal Physiology, Biochemistry and Molecular Biology, College of Life Sciences, Hebei Normal University, Shijiazhuang, China
| | - Z Yu
- Hebei Key Laboratory of Animal Physiology, Biochemistry and Molecular Biology, College of Life Sciences, Hebei Normal University, Shijiazhuang, China
| | - J Liu
- Hebei Key Laboratory of Animal Physiology, Biochemistry and Molecular Biology, College of Life Sciences, Hebei Normal University, Shijiazhuang, China
| |
Collapse
|
118
|
Wang S, Wen G, Tang Y, Yang Y, Peng R, Jing H, Wang J, Zhang J, Zhao X, Sun G, Jin J, Liu Y, Song Y, Fang H, Ren H, Tang Y, Qi S, Li N, Chen B, Lu N, Yu Z, Zhang Y, LI Y. Recurrence Score Helps in Selecting T1-2N1 Breast Cancer Patients for Individualized Postmastectomy Radiotherapy – Joint Analysis of 2793 Patients from Two Institutions. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.700] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
119
|
Wang J, Wang S, Tang Y, Jing H, Sun G, Jin J, Liu Y, Song Y, Wang W, Fang H, Ren H, Yu Z, LI Y. Risk Stratification Model for Prediction of Locoregional Recurrence in Patients with Pathologic T1-2N0 Breast Cancer after Mastectomy. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.697] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
120
|
Sun G, Wang S, Song Y, Jin J, Liu Y, Ren H, Fang H, Zhao X, Song Y, Yu Z, Liu X, Li Y. Radiation-Induced Lymphopenia is Associated with Radiation Fractionation and Predicts Poorer Prognosis in Patients with Breast Cancer. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.2369] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
121
|
Li B, Zhang J, Zhang K, Li G, Zheng A, Li J, Li X, Sun X, Chen S, Chen X, Liu L, Ye S, Liu X, Sheng Y, Ge H, Yu Z, Stchin G, Dai M, Wang J, Liu S. Chemoradiation with ENI versus IFI, High-Dose Versus Standard-Dose Radiation Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma: Preliminary Results of Multicenter, Phase Ⅲ Clinical Trial (NROG 001-Northern Radiation Oncology Group of China). Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.2096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
122
|
Li Y, Yang D, Jia Y, He L, Li J, Yu C, Liao C, Yu Z, Zhang C. Effect of infectious bursal disease virus infection on energy metabolism in embryonic chicken livers. Br Poult Sci 2019; 60:729-735. [PMID: 31328539 DOI: 10.1080/00071668.2019.1647586] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
1. The purpose of this study was to investigate ATP levels and the activities of important enzymes involved in glycolysis and TCA cycle in livers of embryonated chicken eggs infected by infectious bursal disease virus (IBDV).2. Embryonated chicken eggs (9 days) were randomly divided into two groups (50 eggs per group). The first group was inoculated with a very virulent IBDV (vvIBDV) isolate into the chorioallantoic membrane. The second group was maintained as uninfected control eggs and inoculated with physiological saline. Embryo survival was assessed daily, and six embryos were sacrificed at 24, 48, 72, 96, and 120 hpi for examining livers. Viral loads in the livers were evaluated by qRT-PCR. A comparative analysis of markers associated with the regulation of energy metabolism across several functional classes (ATP, pyruvic and lactic acids, mitochondrial protein, NAD+/NADH ratios, and enolase, lactic acid dehydrogenase and the respiratory chain complex I activities) were examined in the context of IBDV infection.3. The results indicated that increases in the enzymatic activities associated with glycolytic metabolism in turn affected the synthesis and cytoplasmic concentrations of ATP at early timepoints in infected chicken embryos. Subsequently, energy metabolism was inhibited through the pathological perturbations of metabolic enzymes and mitochondrial damage, as inferred from reduced ATP generation.4. These results suggested impaired bioenergetics, which may lead to liver dysfunction consequent to IBDV infection, contributing to the disease pathogenesis.
Collapse
Affiliation(s)
- Y Li
- Luoyang Key Laboratory of Animal Disease Prevention and Control, Animal Science and Technology College, Henan University of Science and Technology, Luoyang, People's Republic of China
| | - D Yang
- Luoyang Key Laboratory of Animal Disease Prevention and Control, Animal Science and Technology College, Henan University of Science and Technology, Luoyang, People's Republic of China
| | - Y Jia
- Luoyang Key Laboratory of Animal Disease Prevention and Control, Animal Science and Technology College, Henan University of Science and Technology, Luoyang, People's Republic of China
| | - L He
- Luoyang Key Laboratory of Animal Disease Prevention and Control, Animal Science and Technology College, Henan University of Science and Technology, Luoyang, People's Republic of China
| | - J Li
- Luoyang Key Laboratory of Animal Disease Prevention and Control, Animal Science and Technology College, Henan University of Science and Technology, Luoyang, People's Republic of China
| | - C Yu
- Luoyang Key Laboratory of Animal Disease Prevention and Control, Animal Science and Technology College, Henan University of Science and Technology, Luoyang, People's Republic of China
| | - C Liao
- Luoyang Key Laboratory of Animal Disease Prevention and Control, Animal Science and Technology College, Henan University of Science and Technology, Luoyang, People's Republic of China
| | - Z Yu
- Luoyang Key Laboratory of Animal Disease Prevention and Control, Animal Science and Technology College, Henan University of Science and Technology, Luoyang, People's Republic of China
| | - C Zhang
- Luoyang Key Laboratory of Animal Disease Prevention and Control, Animal Science and Technology College, Henan University of Science and Technology, Luoyang, People's Republic of China
| |
Collapse
|
123
|
Yu Z, Liu Y, Guo JN, Yuan YQ, Li ZS, Yuan Q, Liu YF, Zhao CB, Fang JQ, Xiao KF. Establishment of a model for predicting Gleason score >7 before prostate biopsy. J BIOL REG HOMEOS AG 2019; 33:1113-1118. [PMID: 31389222] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Affiliation(s)
- Z Yu
- Department of Urology, Shenzhen People's Hospital, the Second Affiliated Hospital of Jinan University, Shenzhen, China
| | - Y Liu
- Department of Urology, Shenzhen People's Hospital, the Second Affiliated Hospital of Jinan University, Shenzhen, China
| | - J N Guo
- Department of Urology, Shenzhen People's Hospital, the Second Affiliated Hospital of Jinan University, Shenzhen, China
| | - Y Q Yuan
- Department of Urology, Shenzhen People's Hospital, the Second Affiliated Hospital of Jinan University, Shenzhen, China
| | - Z S Li
- Department of Urology, Shenzhen People's Hospital, the Second Affiliated Hospital of Jinan University, Shenzhen, China
| | - Q Yuan
- Department of Urology, Shenzhen People's Hospital, the Second Affiliated Hospital of Jinan University, Shenzhen, China
| | - Y F Liu
- Department of Urology, Shenzhen People's Hospital, the Second Affiliated Hospital of Jinan University, Shenzhen, China
| | - C B Zhao
- Department of Urology, Shenzhen People's Hospital, the Second Affiliated Hospital of Jinan University, Shenzhen, China
| | - J Q Fang
- Department of Urology, Shenzhen People's Hospital, the Second Affiliated Hospital of Jinan University, Shenzhen, China
| | - K F Xiao
- Department of Urology, Shenzhen People's Hospital, the Second Affiliated Hospital of Jinan University, Shenzhen, China
| |
Collapse
|
124
|
Yu Z, Song YB, Cui Y, Fu AQ. Effects of AIF-1 inflammatory factors on the regulation of proliferation of breast cancer cells. J BIOL REG HOMEOS AG 2019; 33:1085-1095. [PMID: 31389223] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
The purpose of this study was to explore the effect of Allograft Inflammatory Factor 1 (AIF-1) on the regulation of proliferation of breast cancer cells. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), cell culture and counting, and mass spectrometry were performed. The biologically active high-purity recombinant protein rhAIF-1 was obtained by optimizing the rhAIF-1 protein purification system, and MDA-MB-231 and MDA-MB-361 breast cancer cell lines were used. After adding to the culture medium, rhAIF-1 was found to promote cell proliferation in dose-dependent and time-dependent manners. The purified protein rhAIF-1 was marked with rhodamine and incubated with the cells. Confocal imaging analysis revealed that the foreign protein was localized in the cytoplasm, and rhAIF-1 was unevenly distributed in the cytoplasm. Although AIF-1 accumulates around the nucleus, it can not enter the nucleus, suggesting that other factors might be involved in the regulation of cell proliferation. In order to find the possible interacting protein of rhAIF-1, protein immunoprecipitation technique and mass spectrometry were employed, and it was indicated that ADAM28m was the possible interacting protein of rhAIF-1. The interaction between rhAIF-1 and ADAM28m was validated by immunoprecipitation along with Western blotting. It was found that rhAIF-1 could precipitate ADAM28m protein by immunoprecipitation. The results indicated that IF-1 participates in the development of breast cancer by interacting with ADAM28m and activating downstream signaling pathways. It was concluded that AIF-1 provides a new idea for the molecular mechanism of breast cancer cell proliferation and acts as a new target for the prevention and treatment of breast cancer in the future.
Collapse
Affiliation(s)
- Z Yu
- Department of Medical Oncology, Yantaishan Hospital, Yantai, Shandong, China
| | - Y B Song
- Department of Medical Oncology, Yantaishan Hospital, Yantai, Shandong, China
| | - Y Cui
- Department of Oncology, Harbin Chest Hospital, Harbin, Heilongjiang, China
| | - A Q Fu
- Department of Medical Oncology, Yantaishan Hospital, Yantai, Shandong, China
| |
Collapse
|
125
|
Park T, Yang C, Yu Z. Specific inhibitors of lysozyme and peptidases inhibit the growth of the rumen protozoan
Entodinium caudatum
without decreasing feed digestion or fermentation
in vitro. J Appl Microbiol 2019; 127:670-682. [DOI: 10.1111/jam.14341] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2019] [Revised: 05/27/2019] [Accepted: 05/30/2019] [Indexed: 12/01/2022]
Affiliation(s)
- T. Park
- Department of Animal Sciences The Ohio State University Columbus OH USA
| | - C. Yang
- Department of Animal Sciences The Ohio State University Columbus OH USA
| | - Z. Yu
- Department of Animal Sciences The Ohio State University Columbus OH USA
| |
Collapse
|
126
|
Yang J, Yu Z, Zhang Y, Zang G, Zhuan L, Tang Z, Liu Y, Wang T, Wang S, Liu J. Preconditioning of adipose‐derived stem cells by phosphodiesterase‐5 inhibition enhances therapeutic efficacy against diabetes‐induced erectile dysfunction. Andrology 2019; 8:231-240. [DOI: 10.1111/andr.12661] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2018] [Revised: 04/08/2019] [Accepted: 05/06/2019] [Indexed: 12/17/2022]
Affiliation(s)
- J. Yang
- Department of Urology, Tongji Medical CollegeHuazhong University of Science and Technology HubeiChina
- Institute of Urology of Tongji Hospital, Tongji Medical CollegeHuazhong University of Science and Technology HubeiChina
| | - Z. Yu
- Department of Urology, Tongji Medical CollegeHuazhong University of Science and Technology HubeiChina
- Institute of Urology of Tongji Hospital, Tongji Medical CollegeHuazhong University of Science and Technology HubeiChina
| | - Y. Zhang
- Department of Urology, Tongji Medical CollegeHuazhong University of Science and Technology HubeiChina
- Institute of Urology of Tongji Hospital, Tongji Medical CollegeHuazhong University of Science and Technology HubeiChina
| | - G.‐H. Zang
- Department of Urology, Tongji Medical CollegeHuazhong University of Science and Technology HubeiChina
- Institute of Urology of Tongji Hospital, Tongji Medical CollegeHuazhong University of Science and Technology HubeiChina
| | - L. Zhuan
- Department of Urology, Tongji Medical CollegeHuazhong University of Science and Technology HubeiChina
- Institute of Urology of Tongji Hospital, Tongji Medical CollegeHuazhong University of Science and Technology HubeiChina
| | - Z. Tang
- Department of Urology, Tongji Medical CollegeHuazhong University of Science and Technology HubeiChina
- Institute of Urology of Tongji Hospital, Tongji Medical CollegeHuazhong University of Science and Technology HubeiChina
| | - Y. Liu
- Department of Neurology, Tongji Medical College Huazhong University of Science and Technology Hubei China
| | - T. Wang
- Department of Urology, Tongji Medical CollegeHuazhong University of Science and Technology HubeiChina
- Institute of Urology of Tongji Hospital, Tongji Medical CollegeHuazhong University of Science and Technology HubeiChina
| | - S.‐G. Wang
- Department of Urology, Tongji Medical CollegeHuazhong University of Science and Technology HubeiChina
- Institute of Urology of Tongji Hospital, Tongji Medical CollegeHuazhong University of Science and Technology HubeiChina
| | - J.‐H. Liu
- Department of Urology, Tongji Medical CollegeHuazhong University of Science and Technology HubeiChina
- Institute of Urology of Tongji Hospital, Tongji Medical CollegeHuazhong University of Science and Technology HubeiChina
| |
Collapse
|
127
|
Du CX, Yu TT, Liu LT, Xu J, Li ZQ, Yu Z, Zhan FH, Ma XK, Qiu LG, Hao M. PS1347 PHF19 INDUCES EZH2 PHOSPHORYLATION AND PROMOTES DRUG RESISTANCE IN MULTIPLE MYELOMA. Hemasphere 2019. [DOI: 10.1097/01.hs9.0000563668.61800.da] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
128
|
Wu H, Meng Q, Zhou Z, Yu Z. Ferric citrate, nitrate, saponin and their combinations affect in vitro ruminal fermentation, production of sulphide and methane and abundance of select microbial populations. J Appl Microbiol 2019; 127:150-158. [PMID: 31004543 DOI: 10.1111/jam.14286] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2018] [Revised: 04/10/2019] [Accepted: 04/14/2019] [Indexed: 01/22/2023]
Abstract
AIMS This study investigated the effects of ferric citrate, nitrate and saponin, both individually and in combination, on sulphidogenesis, methanogenesis, rumen fermentation and abundances of select microbial populations using in vitro rumen cultures. METHODS AND RESULTS Ferric citrate (50 mg l-1 ), Quillaja saponin (0·6 g l-1 ) and sodium nitrate (5 mmol l-1 ) were used in in vitro ruminal fermentation. Ferric citrate alone, its combination with saponin and/or nitrate lowered the aqueous sulphide concentration and total sulphide production. Methane production was suppressed by nitrate alone (by up to 32·92%), its combination with saponin (25·04%) and with both saponins with nitrate (25·92%). None of the treatments adversely affected feed digestion or rumen fermentation. The population of sulphate-reducing bacteria was increased by nitrate and saponin individually, while that of total Archaea was decreased by nitrate alone and the combination of the three inhibitors. CONCLUSIONS Nitrate and its combination with saponin or both ferric citrate and saponin substantially decreased methane production. Most importantly, the decreased methane production was not at the expense of feed digestion or fermentation. Sulphidogenesis from the sulphate present in the high-sulphur diets can be suppressed competitively by ferric citrate, although it was elevated by saponin and nitrate. SIGNIFICANCE AND IMPACT OF THE STUDY The results of this study demonstrated that combinations of certain methane inhibitors, which have different mechanisms of antimethanogenic actions or inhibit different guilds of microbes involved in methane production and sulphate reduction, can be more effective and practical than individual inhibitors, not only in mitigating enteric methane emission but also in lowering the risk of sulphur-associated polioencephalomalacia in feedlot cattle fed high sulphur diets.
Collapse
Affiliation(s)
- H Wu
- College of Animal Science and Technology and State Key Laboratory of Animal Nutrition, China Agricultural University, Beijing, China.,Department of Animal Sciences, The Ohio State University, Columbus, OH, USA
| | - Q Meng
- College of Animal Science and Technology and State Key Laboratory of Animal Nutrition, China Agricultural University, Beijing, China
| | - Z Zhou
- College of Animal Science and Technology and State Key Laboratory of Animal Nutrition, China Agricultural University, Beijing, China
| | - Z Yu
- Department of Animal Sciences, The Ohio State University, Columbus, OH, USA
| |
Collapse
|
129
|
Peruzy MF, Murru N, Yu Z, Kerkhof PJ, Neola B, Joossens M, Proroga YTR, Houf K. Assessment of microbial communities on freshly killed wild boar meat by MALDI-TOF MS and 16S rRNA amplicon sequencing. Int J Food Microbiol 2019; 301:51-60. [PMID: 31100642 DOI: 10.1016/j.ijfoodmicro.2019.05.005] [Citation(s) in RCA: 27] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2018] [Revised: 05/06/2019] [Accepted: 05/06/2019] [Indexed: 12/22/2022]
Abstract
Wild boars (Sus scrofa) are the most widely distributed large mammals and recent increase in consumption of wild boar meat urges the need of microbiological quality criteria. The aim of the study was to characterize the initial bacterial contamination on freshly-killed wild boar meat using a culture-dependent approach with ISO-methods combined with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry identification and 16S rRNA amplicon sequencing. Moreover, the presence of foodborne pathogens was examined using Real-Time-PCR and confirmed by classical isolation. Analysing 22 unrelated wild boar meat samples showed a higher bacterial contamination level compared to pork, with Salmonella present in almost one third of the samples. A great variability of the microbial contamination between the samples was recorded, as well as complementary results between culturing and 16S rRNA amplicon sequencing as frequently isolated genera were not always detected, and vice versa. Furthermore, the foodborne pathogen Salmonella was never detected with 16S rRNA amplicon sequencing, demonstrating the necessity for a cautious approach in the implementation of new analysis techniques in food safety. The present work determines that attention should be paid to the trade of non-inspected meat directly to retail or consumers.
Collapse
Affiliation(s)
- M F Peruzy
- Department of Veterinary Public Health and Food Safety, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium; Department of Veterinary Medicine and Animal Production, University of Naples "Federico II", Via Delpino 1, 80137 Napoli, Italy; Laboratory of Microbiology, Department of Biochemistry and Microbiology, Ghent University, Karel Lodewijk Ledeganckstraat 35, Ghent, Belgium
| | - N Murru
- Department of Veterinary Medicine and Animal Production, University of Naples "Federico II", Via Delpino 1, 80137 Napoli, Italy.
| | - Z Yu
- Department of Veterinary Public Health and Food Safety, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium; Laboratory of Microbiology, Department of Biochemistry and Microbiology, Ghent University, Karel Lodewijk Ledeganckstraat 35, Ghent, Belgium
| | - P-J Kerkhof
- Department of Veterinary Public Health and Food Safety, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium
| | - B Neola
- Istituto Zooprofilattico Sperimentale del Mezzogiorno, Via Salute, 2, Portici, NA, Italy
| | - M Joossens
- Laboratory of Microbiology, Department of Biochemistry and Microbiology, Ghent University, Karel Lodewijk Ledeganckstraat 35, Ghent, Belgium
| | - Y T R Proroga
- Department of Food Microbiology, Istituto Zooprofilattico Sperimentale del Mezzogiorno, Via Salute, 2, Portici, NA, Italy
| | - K Houf
- Department of Veterinary Public Health and Food Safety, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium
| |
Collapse
|
130
|
Wang P, Long Z, Yu Z, Liu P, Wei D, Fang Q, Ma D, Wang J. The efficacy of topical gentamycin application on prophylaxis and treatment of wound infection: A systematic review and meta-analysis. Int J Clin Pract 2019; 73:e13334. [PMID: 30809868 DOI: 10.1111/ijcp.13334] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/11/2018] [Revised: 01/03/2019] [Accepted: 02/24/2019] [Indexed: 01/19/2023] Open
Abstract
OBJECTIVES The purpose of this study was to conduct a systematic review and meta-analysis in patients with local wound infection or infective risk, evaluating effects of topical gentamycin application on prophylaxis and treatment of wound infection. METHODS Embase, the Cochrane Library, Pubmed, Medline (from Ovid) and three Chinese literature databases (CNKI, VIP and WANFANG) were searched. Randomised controlled studies (RCTs) and observational studies (OSs) that assessed the efficacy of topical gentamycin application on prophylaxis and treatment of local wound infection were included. The primary outcome was clinical efficacy. Secondary outcomes included duration of recovery time and length of hospital stay. RESULTS Fifteen studies (1781 patients) met inclusion criteria. Twelve studies were RCTs and other three studies were OSs. Compared with non-gentamycin group, topical gentamycin application had significantly higher rates of clinical efficacy (OR = 3.57, 95% CI 2.52-5.07). In terms of duration of wound healing, it's taken shorter time in gentamycin group than non-gentamycin group (OR = -4.94, 95% CI -8.37 to -1.51). However, the length of hospital stay had no significantly difference between the two groups (OR = -3.40, 95% CI -8.42 to 1.63). Subgroup analyses were conducted according to study design (RCTs or OSs), purpose and administration type. And the results showed that there were no significant difference of clinical efficacy in study design (P = 0.21, I2 = 35.4%), purpose (P = 0.32, I2 = 0%) and administration type subgroup (P = 0.74, I2 = 0%). However, topical gentamycin application had significantly shorter duration of wound healing in randomly controlled trials compared with observational studies, but had no difference in terms of administration type(P = 0.20, I2 = 38.6%). CONCLUSIONS Studies to date show that topical gentamycin application significantly increases the rate of clinical efficacy and decreases the duration of wound healing in patients with local wound infection or infective risk.
Collapse
Affiliation(s)
- Ping Wang
- Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang, P. R. China
| | - Zhengmei Long
- Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang, P. R. China
| | - Zhengyu Yu
- Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang, P. R. China
| | - Ping Liu
- Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang, P. R. China
| | - Danna Wei
- Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang, P. R. China
| | - Qin Fang
- Department of Pharmacy, Affiliated Baiyun Hospital of Guizhou Medical University, Guiyang, P. R. China
- Department of Pharmacy, Affiliated Hospital of Guizhou Medical University, Guiyang, P. R. China
| | - Dan Ma
- Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang, P. R. China
| | - Jishi Wang
- Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang, P. R. China
| |
Collapse
|
131
|
Hristov AN, Bannink A, Crompton LA, Huhtanen P, Kreuzer M, McGee M, Nozière P, Reynolds CK, Bayat AR, Yáñez-Ruiz DR, Dijkstra J, Kebreab E, Schwarm A, Shingfield KJ, Yu Z. Invited review: Nitrogen in ruminant nutrition: A review of measurement techniques. J Dairy Sci 2019; 102:5811-5852. [PMID: 31030912 DOI: 10.3168/jds.2018-15829] [Citation(s) in RCA: 80] [Impact Index Per Article: 16.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2018] [Accepted: 02/27/2019] [Indexed: 01/17/2023]
Abstract
Nitrogen is a component of essential nutrients critical for the productivity of ruminants. If excreted in excess, N is also an important environmental pollutant contributing to acid deposition, eutrophication, human respiratory problems, and climate change. The complex microbial metabolic activity in the rumen and the effect on subsequent processes in the intestines and body tissues make the study of N metabolism in ruminants challenging compared with nonruminants. Therefore, using accurate and precise measurement techniques is imperative for obtaining reliable experimental results on N utilization by ruminants and evaluating the environmental impacts of N emission mitigation techniques. Changeover design experiments are as suitable as continuous ones for studying protein metabolism in ruminant animals, except when changes in body weight or carryover effects due to treatment are expected. Adaptation following a dietary change should be allowed for at least 2 (preferably 3) wk, and extended adaptation periods may be required if body pools can temporarily supply the nutrients studied. Dietary protein degradability in the rumen and intestines are feed characteristics determining the primary AA available to the host animal. They can be estimated using in situ, in vitro, or in vivo techniques with each having inherent advantages and disadvantages. Accurate, precise, and inexpensive laboratory assays for feed protein availability are still needed. Techniques used for direct determination of rumen microbial protein synthesis are laborious and expensive, and data variability can be unacceptably large; indirect approaches have not shown the level of accuracy required for widespread adoption. Techniques for studying postruminal digestion and absorption of nitrogenous compounds, urea recycling, and mammary AA metabolism are also laborious, expensive (especially the methods that use isotopes), and results can be variable, especially the methods based on measurements of digesta or blood flow. Volatile loss of N from feces and particularly urine can be substantial during collection, processing, and analysis of excreta, compromising the accuracy of measurements of total-tract N digestion and body N balance. In studying ruminant N metabolism, nutritionists should consider the longer term fate of manure N as well. Various techniques used to determine the effects of animal nutrition on total N, ammonia- or nitrous oxide-emitting potentials, as well as plant fertilizer value, of manure are available. Overall, methods to study ruminant N metabolism have been developed over 150 yr of animal nutrition research, but many of them are laborious and impractical for application on a large number of animals. The increasing environmental concerns associated with livestock production systems necessitate more accurate and reliable methods to determine manure N emissions in the context of feed composition and ruminant N metabolism.
Collapse
Affiliation(s)
- A N Hristov
- Department of Animal Science, The Pennsylvania State University, University Park 16802.
| | - A Bannink
- Wageningen Livestock Research, Wageningen University & Research, PO Box 338, 6700 AH Wageningen, the Netherlands
| | - L A Crompton
- School of Agriculture, Policy and Development, Centre for Dairy Research, University of Reading, PO Box 237 Earley Gate, Reading RG6 6AR, United Kingdom
| | - P Huhtanen
- Department of Agricultural Science, Swedish University of Agricultural Sciences, S-90, Umeå, Sweden
| | - M Kreuzer
- ETH Zurich, Institute of Agricultural Sciences, Universitaetstrasse 2, 8092 Zurich, Switzerland
| | - M McGee
- Teagasc, Animal & Grassland Research and Innovation Centre, Grange, Dunsany, Co. Meath, Ireland C15 PW93
| | - P Nozière
- Université Clermont Auvergne, INRA, VetAgro Sup, UMR Herbivores, F-63122 Saint-Genès-Champanelle, France
| | - C K Reynolds
- School of Agriculture, Policy and Development, Centre for Dairy Research, University of Reading, PO Box 237 Earley Gate, Reading RG6 6AR, United Kingdom
| | - A R Bayat
- Milk Production Solutions, Production Systems, Natural Resources Institute Finland (Luke), FI 31600 Jokioinen, Finland
| | - D R Yáñez-Ruiz
- Estación Experimental del Zaidín (CSIC), Profesor Albareda, 1, 18008, Granada, Spain
| | - J Dijkstra
- Animal Nutrition Group, Wageningen University & Research, PO Box 338, 6700 AH, Wageningen, the Netherlands
| | - E Kebreab
- Department of Animal Science, University of California, Davis 95616
| | - A Schwarm
- ETH Zurich, Institute of Agricultural Sciences, Universitaetstrasse 2, 8092 Zurich, Switzerland
| | - K J Shingfield
- Milk Production Solutions, Production Systems, Natural Resources Institute Finland (Luke), FI 31600 Jokioinen, Finland; Institute of Biological, Environmental and Rural Sciences, Aberystwyth University, Aberystwyth, SY23 3EB, United Kingdom
| | - Z Yu
- Department of Animal Sciences, The Ohio State University, Columbus 43210
| |
Collapse
|
132
|
Xu C, Wang W, Zhu Y, Yu Z, Zhang H, Wang H, Zhang J, Zhuang W, Lv T, Song Y. Potential resistance mechanisms using next generation sequencing from Chinese EGFR T790M+ non-small cell lung cancer patients with primary resistance to osimertinib: A multicenter study. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz063.012] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
133
|
Wu Q, Zhou F, Song NX, Liu XM, Yu Z, Song XC, Li X, Zhang H. [Clinical features and risk factors of hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi 2019; 40:187-190. [PMID: 30929383 PMCID: PMC7342539 DOI: 10.3760/cma.j.issn.0253-2727.2019.03.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Download PDF] [Subscribe] [Scholar Register] [Received: 07/03/2018] [Indexed: 12/27/2022]
Abstract
Objective: To explore the relative risk factors, clinical intervention and prognosis of hemorrhagic cystitis (HC) in patients with allogeneic hematopoietic stem cell transplantation (allo-HSCT) . Methods: From January 1 2010 to May 31 2017, 425 patients with allo-HSCT received a retrospective analysis. Results: ①Among the 425 patients, 262 were male and 163 were female. The median age was 26 (2-56) years old. There were 138 cases of acute myeloid leukemia (AML) , 96 cases of acute lymphoblastic leukemia (ALL) , 29 cases of myelodysplastic syndrome (MDS) , 98 cases of severe aplastic anemia (SAA) and 64 cases of chronic myeloid leukemia (CML) . 221 cases of sibling match transplantation, 89 cases of unrelated donor transplantation and 115 cases of haplotype transplantation. ②108 patients (25.41%) developed HC, with the median time of onset of 32 (3-243) days and the median duration of 20 (3-93) days; 33 cases (30.56%) were grade Ⅰ, 49 cases of grade Ⅱ (45.36%) , 21 cases (19.44%) of grade Ⅲ, and 5 cases (4.63%) of grade Ⅳ. ③103 cases of HC were cured, 5 patients were ineffective, 12 patients died and died of transplantation related complications (infection, recurrence, severe acute GVHD, secondary implant failure) . ④Univariate analysis showed that age < 30, type of transplantation, CMV and acute GVHD were associated with the occurrence of HC after allo-HSCT. Multivariate analysis showed that acute GVHD was an independent risk factor for HC after allo-HSCT. Conclusion: Prognosis of HC after allo-HSCT was better after timely treatment.
Collapse
Affiliation(s)
- Q Wu
- Department of Hematology, PLA 960 Hospital, Jinan 250031, China
| | | | | | | | | | | | | | | |
Collapse
|
134
|
Chen Z, Yu Z, Shao Z, Ding X, Wang S, Jing S, Tong Y, Li Q. Integrin β3 interacts with Toll-like receptor 4 to up-regulate CD14 expression in macrophages and contributes to sepsis induced acute lung injury. Br J Anaesth 2019. [DOI: 10.1016/j.bja.2018.10.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
135
|
Song Y, Zhou F, Song NX, Liu XM, Yu Z, Xie LN, Song XC, Li X. [Impact on platelet recovery of recombinant human thrombopoietin in severe aplastic anemia patients with allogeneic hematopoietic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi 2019; 39:207-211. [PMID: 29562465 PMCID: PMC7342989 DOI: 10.3760/cma.j.issn.0253-2727.2018.03.007] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
目的 分析重组人血小板生成素(rhTPO)促进重型再生障碍性贫血(SAA)患者异基因造血干细胞移植(allo-HSCT)后血小板恢复的疗效及安全性。 方法 对2010年1月至2017年3月期间85例接受allo-HSCT治疗的SAA患者进行回顾性分析。根据移植后升血小板药物的使用情况,将85例患者分为rhTPO组(29例)、rhIL-11组(27例)和空白组(29例),比较三组PLT≥20×109/L、PLT≥50×109/L、PLT≥100×109/L的恢复时间以及移植后(25±5)d骨髓巨核细胞计数、移植期间血小板输注量,观察药物不良反应。 结果 rhTPO、rhIL-11、空白组粒细胞植入和PLT≥20×109/L的中位时间差异均无统计学意义(P>0.05)。rhTPO组PLT≥50×109/L时间短于空白组[16.5(11~39)d对22(14~66)d,P<0.05];rhTPO组PLT≥100×109/L时间[23(12~51)d]短于rhIL-11组[28(12~80)d]及空白组[35(18~86)d](P<0.05)。rhTPO组移植期间血小板输注量少于rhIL-11组及空白组[分别为20(10~30)、30(10~50)、35(10~70)U,P<0.05]。rhTPO、rhIL-11、空白组移植后(25±5)d骨髓巨核细胞中位计数分别为31.5(0~200)、12(0~142)、11(0~187)个,rhTPO组与rhIL-11组比较差异有统计学意义(P<0.05),rhIL-11组与空白组比较差异无统计学意义(P>0.05)。多因素分析显示,应用rhTPO是影响血小板恢复的独立影响因素[HR=4.01(95%CI 1.81~8.97),P=0.010]。rhTPO组未见明显不良反应。 结论 rhTPO可以促进SAA患者allo-HSCT后血小板恢复、减少血小板输注量,并且安全性较好。
Collapse
Affiliation(s)
- Y Song
- Department of Hematology, The General Hospital of Jinan Military Command, Jinan 250031, China
| | | | | | | | | | | | | | | |
Collapse
|
136
|
Yu Z, He S, Miller C, Saeh J, Hattersley G, O'Neill A. Abstract P4-13-02: Selective androgen receptor modulator RAD140 inhibits the growth of endocrine-resistant breast cancer models with defined genetic backgrounds. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p4-13-02] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Estrogen receptor α-positive (ER+) breast cancer is routinely treated with therapies targeting the ER axis. However, de novo and acquired resistance to the standard-of-care treatment occur in a significant subset of patients. Multiple mechanisms have been proposed for the resistance, among which genetic alterations to the coding gene of ERα, ESR1, have been extensively studied. Notably, ESR1 hotspot mutations within the ligand binding domain (LBD), novel fusion proteins consisting of the N-terminal domain of ER and the C-terminal domain of a partner gene, and ESR1 gene amplification have been found to be enriched in endocrine-resistant, metastatic breast cancers. Together these ER gene alterations present new challenges in the management of ER+ breast cancer and call for the development of new agents to supplement the current standard-of-care. Around 90% of the ER+ breast cancer cases are also androgen receptor (AR) positive (AR+). Mounting preclinical evidence has demonstrated that AR agonists suppress AR and ER positive (AR/ER+) breast cancer cell growth, in line with clinical activity of androgens. We recently reported the oral selective androgen receptor modulator (SARM) RAD140 is a potent, tissue-selective AR agonist in breast cancer cells which significantly inhibited the growth of AR/ER+ patient-derived xenograft (PDX) models, partly via inhibiting ESR1 gene expression and ER signaling. It also elicited enhanced tumor growth inhibition when combined with a CDK4/6 inhibitor.
Here we further examine the activity of RAD140 in AR/ER+ breast cancer models that are endocrine-independent with a spectrum of ESR1 genetic alterations. In PDX models harboring ESR1 amplification or fusion, RAD140 inhibited tumor growth to a greater degree than fulvestrant, a standard-of-care selective ER degrader (SERD). These results are consistent with the clinical history of the donor patients whose diseases relapsed from or progressed rapidly on fulvestrant. In PDX models with ESR1 Y537S mutation, RAD140 showed anti-tumor activity comparable to that of fulvestrant. Notably, RAD140 treatment also led to substantial reduction of proliferation and colony formation in cell line models recapitulating resistance to the combination of estrogen deprivation and CDK4/6 inhibition.
In summary, RAD140 showed marked anti-tumor activity in AR/ER+, endocrine-resistant breast cancer models with defined genetic background. Importantly, in models with ESR1 amplification and fusion, the AR-targeting RAD140 exhibited more profound inhibitory activity compared with fulvestrant. In models with an ESR1 mutation, the efficacy of RAD140 and fulvestrant was comparable. These results lend support to a clinical hypothesis that AR/ER+, endocrine-resistant tumors with these genetic backgrounds may benefit from AR agonist-based treatment. RAD140 is currently being evaluated in hormone receptor positive (HR+) breast cancer patients (NCT03088527).
Citation Format: Yu Z, He S, Miller C, Saeh J, Hattersley G, O'Neill A. Selective androgen receptor modulator RAD140 inhibits the growth of endocrine-resistant breast cancer models with defined genetic backgrounds [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P4-13-02.
Collapse
Affiliation(s)
- Z Yu
- Radius Health, Inc, Waltham
| | - S He
- Radius Health, Inc, Waltham
| | | | - J Saeh
- Radius Health, Inc, Waltham
| | | | | |
Collapse
|
137
|
Zhang X, Yu Z. Expression of PDK1 in malignant pheochromocytoma as a new promising potential therapeutic target. Clin Transl Oncol 2019; 21:1312-1318. [DOI: 10.1007/s12094-019-02055-5] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2018] [Accepted: 01/29/2019] [Indexed: 01/03/2023]
|
138
|
Peruzy M, Murru N, Yu Z, Cnockaert M, Joossens M, Proroga Y, Houf K. Determination of the microbiological contamination in minced pork by culture dependent and 16S amplicon sequencing analysis. Int J Food Microbiol 2019; 290:27-35. [DOI: 10.1016/j.ijfoodmicro.2018.09.025] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2018] [Revised: 09/14/2018] [Accepted: 09/28/2018] [Indexed: 12/22/2022]
|
139
|
Feng LX, Wang J, Yu Z, Song SA, Zhai WX, Dong SH, Yu HS, Zhang Y. Clinical significance of serum EGFR gene mutation and serum tumor markers in predicting tyrosine kinase inhibitor efficacy in lung adenocarcinoma. Clin Transl Oncol 2019; 21:1005-1013. [DOI: 10.1007/s12094-018-02014-6] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2018] [Accepted: 12/10/2018] [Indexed: 02/07/2023]
|
140
|
Ma D, Wang P, Fang Q, Yu Z, Zhou Z, He Z, Wei D, Yu K, Lu T, Zhang Y, Wang J. Low-dose staurosporine selectively reverses BCR-ABL-independent IM resistance through PKC-α-mediated G2/M phase arrest in chronic myeloid leukaemia. Artificial Cells, Nanomedicine, and Biotechnology 2019; 46:S208-S216. [PMID: 30618318 DOI: 10.1080/21691401.2018.1490310] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Affiliation(s)
- Dan Ma
- Department of Hematology, Key Laboratory of Hematological Disease Diagnostic & Treat Centre of Guizhou Province, Affiliated Hospital of Guizhou Medical University, Guizhou Province Institute of Hematology, Guiyang, China
| | - Ping Wang
- Department of Hematology, Key Laboratory of Hematological Disease Diagnostic & Treat Centre of Guizhou Province, Affiliated Hospital of Guizhou Medical University, Guizhou Province Institute of Hematology, Guiyang, China
| | - Qin Fang
- Department of Pharmacy, Affiliated Baiyun Hospital of Guizhou Medical University, Guiyang, China
- Department of Pharmacy, Affiliated Hospital of Guiyang Medical University, Guiyang, China
| | - Zhengyu Yu
- Department of Hematology, Key Laboratory of Hematological Disease Diagnostic & Treat Centre of Guizhou Province, Affiliated Hospital of Guizhou Medical University, Guizhou Province Institute of Hematology, Guiyang, China
| | - Zhen Zhou
- Department of Hematology, Key Laboratory of Hematological Disease Diagnostic & Treat Centre of Guizhou Province, Affiliated Hospital of Guizhou Medical University, Guizhou Province Institute of Hematology, Guiyang, China
- Department of Pharmacy, Affiliated Baiyun Hospital of Guizhou Medical University, Guiyang, China
- Department of Pharmacy, Affiliated Hospital of Guiyang Medical University, Guiyang, China
| | - Zhengchang He
- Department of Hematology, Key Laboratory of Hematological Disease Diagnostic & Treat Centre of Guizhou Province, Affiliated Hospital of Guizhou Medical University, Guizhou Province Institute of Hematology, Guiyang, China
| | - Danna Wei
- Department of Hematology, Key Laboratory of Hematological Disease Diagnostic & Treat Centre of Guizhou Province, Affiliated Hospital of Guizhou Medical University, Guizhou Province Institute of Hematology, Guiyang, China
| | - Kunling Yu
- Department of Hematology, Key Laboratory of Hematological Disease Diagnostic & Treat Centre of Guizhou Province, Affiliated Hospital of Guizhou Medical University, Guizhou Province Institute of Hematology, Guiyang, China
| | - Tingting Lu
- Department of Hematology, Key Laboratory of Hematological Disease Diagnostic & Treat Centre of Guizhou Province, Affiliated Hospital of Guizhou Medical University, Guizhou Province Institute of Hematology, Guiyang, China
| | - Yaming Zhang
- Department of Hematology, Key Laboratory of Hematological Disease Diagnostic & Treat Centre of Guizhou Province, Affiliated Hospital of Guizhou Medical University, Guizhou Province Institute of Hematology, Guiyang, China
| | - Jishi Wang
- Department of Hematology, Key Laboratory of Hematological Disease Diagnostic & Treat Centre of Guizhou Province, Affiliated Hospital of Guizhou Medical University, Guizhou Province Institute of Hematology, Guiyang, China
| |
Collapse
|
141
|
Yu Z, Liu W, Deng Y, Yao J, Tang H, Li H, Yang Y, Wang G, Chen G. Significant Efficacy of Apatinib in a Patient With Hepatocellular Carcinoma Lung Metastases After Liver Transplantation: A Case Report. Transplant Proc 2018; 50:4042-4045. [PMID: 30577311 DOI: 10.1016/j.transproceed.2018.06.044] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2018] [Accepted: 06/27/2018] [Indexed: 12/26/2022]
Abstract
Antiangiogenesis therapy plays an important role in the treatment of advanced hepatocellular carcinoma (HCC). However, treatment options for HCC recurrence after liver transplantation are currently limited. Apatinib is a small tyrosine kinase inhibitor molecule targeting vascular endothelial growth factor receptor-2. Here, we report for the first time one case of a patient with advanced HCC who received apatinib after occurring lung metastasis 7 months after liver transplantation. He took 500 mg of apatinib daily for one month, which was decreased to 250 mg daily because of side effects. The patient was confirmed to have a partial response, according to the Response Evaluation Criteria in Solid Tumors, for 10 months, and the progression-free survival time was greater than 21 months. Our data and experience have indicated that apatinib may be a good choice for HCC recurrence after liver transplantation.
Collapse
Affiliation(s)
- Z Yu
- Department of Hepatic Surgery and Liver Transplantation Center of the Third Affiliated Hospital, Organ Transplantation Institute, Sun Yat-sen University, Organ Transplantation Research Center of Guangdong Province, Guangzhou, China
| | - W Liu
- Guangdong Key Laboratory of Liver Disease Research, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
| | - Y Deng
- Department of Hepatic Surgery and Liver Transplantation Center of the Third Affiliated Hospital, Organ Transplantation Institute, Sun Yat-sen University, Organ Transplantation Research Center of Guangdong Province, Guangzhou, China
| | - J Yao
- Department of Hepatic Surgery and Liver Transplantation Center of the Third Affiliated Hospital, Organ Transplantation Institute, Sun Yat-sen University, Organ Transplantation Research Center of Guangdong Province, Guangzhou, China
| | - H Tang
- Department of Hepatic Surgery and Liver Transplantation Center of the Third Affiliated Hospital, Organ Transplantation Institute, Sun Yat-sen University, Organ Transplantation Research Center of Guangdong Province, Guangzhou, China
| | - H Li
- Department of Hepatic Surgery and Liver Transplantation Center of the Third Affiliated Hospital, Organ Transplantation Institute, Sun Yat-sen University, Organ Transplantation Research Center of Guangdong Province, Guangzhou, China
| | - Y Yang
- Department of Hepatic Surgery and Liver Transplantation Center of the Third Affiliated Hospital, Organ Transplantation Institute, Sun Yat-sen University, Organ Transplantation Research Center of Guangdong Province, Guangzhou, China; Guangdong Key Laboratory of Liver Disease Research, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
| | - G Wang
- Department of Hepatic Surgery and Liver Transplantation Center of the Third Affiliated Hospital, Organ Transplantation Institute, Sun Yat-sen University, Organ Transplantation Research Center of Guangdong Province, Guangzhou, China.
| | - G Chen
- Guangdong Key Laboratory of Liver Disease Research, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
| |
Collapse
|
142
|
Zhang C, Wang G, Yu Z, Liu H, Liu H. P006 Evaluation of Efficacy and Safety of Uniportal Segmentectomy in the Treatment of Small Lung Nodule. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.10.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
143
|
Wang G, Zhang C, Liu H, Yu Z, Liu H. P017 Investigation of Mediastinal Lymph Node Metastasis in Non-Small Cell Lung Cancer. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.10.041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
144
|
Liu H, Ma Y, Yu Z, Ren Y, Zhang C, Wang G, Liu H. P024 Sleeve Lobectomy for Centrally Located Non-Small Cell Lung Cancer: Experience of a Single Institute. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.10.048] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
145
|
Yu Z, Ramamurthy NS, Leung M, Chang KM, McNamara TF, Golub LM. Chemically-modified tetracycline normalizes collagen metabolism in diabetic rats: a dose-response study. J Periodontal Res 2018. [DOI: 10.1111/jre.1993.28.6.420] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
146
|
Ma G, Yu Z, Liu F, Wang L, Yu W, Zhu J, Gu H, Liu Y, Cai R, Lin X. GNAQ mutation in port-wine macrocheilia. Br J Dermatol 2018. [DOI: 10.1111/bjd.17213] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
147
|
Wang S, Tang Y, Fang H, Sun G, Jing H, Song Y, Wang J, Jin J, Liu Y, Ren H, Yu Z, Li Y. Breast Conservation Therapy Achieved Comparable Outcomes with Mastectomy in Patients with T1-2N0 Triple-Negative Breast Cancer: Analysis of 822 Patients in a Single Institution. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2018.07.1634] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
148
|
Hirschman KB, Yu Z, Pennock MJ, Pepe K, Rouse W, Pauly MV, Naylor MD. WHAT FACTORS ARE IMPORTANT WHEN DECIDING TO ADOPT THE EVIDENCE-BASED TRANSITIONAL CARE MODEL (TCM)? Innov Aging 2018. [DOI: 10.1093/geroni/igy023.2269] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- K B Hirschman
- NewCourtland Center for Transitions and Health, University of Pennsylvania, School of Nursing, Philadelphia, Pennsylvania, United States
| | - Z Yu
- Stevens Institute of Technology, School of Systems and Enterprises, Hoboken, NJ, USA
| | - M J Pennock
- Stevens Institute of Technology, School of Systems and Enterprises, Hoboken, NJ, USA
| | - K Pepe
- Stevens Institute of Technology, School of Systems and Enterprises, Hoboken, NJ, USA
| | - W Rouse
- Stevens Institute of Technology, School of Systems and Enterprises, Hoboken, NJ, USA
| | - M V Pauly
- The Wharton School, University of Pennsylvania, Philadelphia, PA, USA
| | - M D Naylor
- NewCourland Center for Transitions and Health, University of Pennsylvania School of Nursing, Philadelphia, PA, USA
| |
Collapse
|
149
|
Chen B, Li Y, Wang S, Jin J, Liu Y, Song Y, Fang H, Qi S, Tang Y, Hua R, Li N, Tang Y, Yu Z, Yang Y, Liu W. Hemophagocytic Syndrome in Early Stage Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2018.07.795] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
150
|
Wang S, Tang Y, Sun G, Fang H, Wang J, Jing H, Jin J, Song Y, Liu Y, Ren H, Yu Z, Li Y. Mastectomy Without Radiation Therapy Had Inferior Outcomes As Compared to Breast Conserving Surgery or Mastectomy Plus Radiation Therapy in Patients with T1-2N1 Triple-Negative Breast Cancer: Analysis of 412 Patients in a Single Institution. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2018.07.1636] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|